共 50 条
- [4] Galcanezumab effects on incidence of headache after occurrence of triggers, premonitory symptoms, and aura in responders, non-responders, super-responders, and super non-responders JOURNAL OF HEADACHE AND PAIN, 2023, 24 (01):
- [5] Super-Responders and Non-Responders to CGRP Monoclonal Antibodies in the Treatment of Migraine HEADACHE, 2020, 60 : 25 - 26
- [10] Clinical evaluation of super-responders vs. non-responders to CGRP(-receptor) monoclonal antibodies: a real-world experience The Journal of Headache and Pain, 24